Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Promise Of Pigs: Kidney Still Functioning A Month After Xenotransplantation

Executive Summary

More than a month after surgeons at NYU Langone Health transplanted a pig kidney into a human being, the animal organ is still working. Surgeons say this is the longest a gene-edited pig kidney has functioned in a human body.

You may also be interested in...



From The Farm To The OR: Pigs Show More Promise As Organ Donors

Surgeons in Alabama have taken a giant leap forward to making pig kidneys a viable option for humans with end-stage renal disease.

Swedish Company’s Novel Device At The Heart Of Milestone Transplant Surgery

An organ preservation system from Swedish medical technology company XVIVO played a key role in the first successful transplant of a pig heart into a human patient.

News We’re Watching: Free COVID-19 Tests, Edwards Antitrust Investigation, McKinsey Calls For Medtech ‘Reinvention’

This week, the US government relaunched a program providing free COVID-19 tests and invested $600m in domestic test manufacturing; the European Commission revealed an antitrust investigation of Edwards LifeSciences; and a consulting firm report said the medtech industry should make big changes to address investor skepticism.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT148185

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel